Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Cell Cycle (Georgetown, Tex.)|March 3, 2007
Notch, Myc and breast cancerArgiris Efstratiadis, Matthias Szabolcs, Apostolos KlinakisProceedings of the National Academy of Sciences of the United States of America|November 27, 2008
The hormonal action of IGF1 in postnatal mouse growthElias Stratikopoulos, Matthias Szabolcs, Ioannis Dragatsis, et al.Proceedings of the National Academy of Sciences of the United States of America|January 29, 2009
Igf1r as a therapeutic target in a mouse model of basal-like breast cancerApostolos Klinakis, Matthias Szabolcs, Guoying Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 2006
Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in miceApostolos Klinakis, Matthias Szabolcs, Katerina Politi, et al.Journal of the National Cancer Institute|October 13, 2014
Therapeutic effects of an anti-Myc drug on mouse pancreatic cancerDimitris Stellas, Matthias Szabolcs, Sanjay Koul, et al.Carcinogenesis|January 13, 2006
Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgeneZhe Li, Matthias Szabolcs, Joseph D Terwilliger, et al.The Journal of Biological Chemistry|October 16, 2010
Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cellsShouhong Xuan, Matthias Szabolcs, Francesca Cinti, et al.The American Journal of Pathology|December 26, 2003
A mouse model of uterine leiomyosarcomaKaterina Politi, Matthias Szabolcs, Peter Fisher, et al.Oncogene|December 9, 2003
'Designer' tumors in miceKaterina Politi, Ana Kljuic, Matthias Szabolcs, et al.The American Journal of Pathology|July 28, 2004
Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epitheliumHippokratis Kiaris, Katerina Politi, Lisa M Grimm, et al.Pageof 12